No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder worldwide, reaching prevalence up to 90 % in obese patients with type 2 diabetes (T2D), and representing an independent risk factor for cardiovascular mortality. Furthermore, the coexistence of T2D and NAFLD le...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Med
Prif Awduron: Barchetta, Ilaria, Del Ben, Maria, Angelico, Francesco, Di Martino, Michele, Fraioli, Antonio, La Torre, Giuseppe, Saulle, Rosella, Perri, Ludovica, Morini, Sergio, Tiberti, Claudio, Bertoccini, Laura, Cimini, Flavia Agata, Panimolle, Francesca, Catalano, Carlo, Baroni, Marco Giorgio, Cavallo, Maria Gisella
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2016
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4926287/
https://ncbi.nlm.nih.gov/pubmed/27353492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0638-y
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg